NCT02686229

Brief Summary

The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
128mo left

Started Nov 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Nov 2015Dec 2036

Study Start

First participant enrolled

November 15, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 19, 2016

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
9.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2036

Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

11.1 years

First QC Date

February 4, 2016

Last Update Submit

May 10, 2023

Conditions

Keywords

Low grade glioma, registry, neurosurgery, brain tumor

Outcome Measures

Primary Outcomes (2)

  • Progression-free survival (PFS)

    5yrs

  • Overall survival (OS)

    15yrs

Secondary Outcomes (2)

  • Extent of tumor resection

    3yrs

  • Quality of life (QoL) assessed by the EORTC QLQ C-30/BN-20. (European Organisation for Research and Treatment of Cancer Quality of Life Questionaire C-30

    5yrs

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All adult patients with radiological suspected diagnosis of a low grade glioma

You may qualify if:

  • Patients with radiological suspected diagnosis of a low grade glioma
  • Age ≥ 18 years. There is no upper age limit.

You may not qualify if:

  • Severe neurological or psychiatric disorder interfering with ability to give an informed consent
  • No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation
  • No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ulm

Ulm, Germany

RECRUITING

Related Publications (1)

  • Pala A, Nadji-Ohl M, Faust K, Ruckriegel S, Roder C, von der Brelie C, Forster MT, Lobel F, Schommer S, Lohr M, Renovanz M, Grubel N, Rothenbacher D, Konig R, Engelke J, Schmitz B, Wirtz CR, Ringel F, Senft C, Rohde V, Tatagiba M, Ernestus RI, Vajkoczy P, Ganslandt O, Nagel G, Coburger J. Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio Project. J Neurol Surg A Cent Eur Neurosurg. 2020 Jan;81(1):48-57. doi: 10.1055/s-0039-1693650. Epub 2019 Sep 24.

Biospecimen

Retention: SAMPLES WITH DNA

Blood and tumor samples

MeSH Terms

Conditions

GliomaBrain Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Glandular and EpithelialNeoplasms, Nerve TissueCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

February 4, 2016

First Posted

February 19, 2016

Study Start

November 15, 2015

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 1, 2036

Last Updated

May 11, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations